<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" href="./css/bootstrap.min.css">
    <link rel="stylesheet" href="./css/all.min.css">
    <link rel="stylesheet" href="./css/fontawesome.min.css">
    <link rel="stylesheet" href="./css/style.css">
    <title>Diabetes 360 eMagazine</title>
</head>
<body>


    <div class="container">
    <div class="main">
        <div class="left">
            <a href="./page-10.html"><img src="./img/prev.png" alt="previous"></a>
        </div>
        <div class="right">
            <a href="./page-12.html"><img src="./img/next.png" alt="next"></a>
        </div>
        
        <header class="pages-header-footer pages-h-f-white">
            <div class="row align-items-center m-0">
                <div class="col-3 header-txt header-txt-black"><p class=" m-0">NEWSLETTER in Diabetes</p></div>
                <div class="col-7 align-content-center"><div class="dark-line"></div></div>
                <div class="col-2"><img src="img/sanofi-logo-black.png" alt=""></div>
            </div>
        </header>
        <div class="article-head">
            <h1 class="headline"><span class="bold">
                Time in Range, as Measured by Continuous Glucose
Monitor, as a Predictor of Microvascular Complications
in Type 2 Diabetes:
            </span>
            A Systematic Review</h1>
                <hr>
            <div class="subheader">
                <p class="primary-col">
                    Source: Raj R, Mishra R, Jha N, Joshi V, Correa R, Kern PA. Time in range, as measured by continuous glucose monitor, as a predictor
                    of microvascular complications in type 2 diabetes: a systematic review. BMJ Open Diabetes Res Care. 2022 Jan;10(1):e002573.
                </p>
            </div>
        </div>
        <article>
            <div class="row">
                <div class="col-lg-6 col-sm-12">
                    <div class="feature-img">
                        <img src="./img/magazine-edit-13-3-21.jpg" alt="feature-img">
                    </div>
                    <p>
                        Continuous glucose monitoring (CGM)-derived time in
range (TIR) correlates with hemoglobin A1c (A1c) among
patients with type 2 diabetes mellitus (T2DM); however,
there is a paucity of data evaluating its association with
microvascular complications. Raj et al., conducted this
systematic review to examine the association between TIR
and microvascular complications of diabetic retinopathy
(DR), diabetic nephropathy (DN), and diabetic peripheral
neuropathy (DPN).
                    </p>
                        <p>
                            This systematic review, which included 11 studies
                            with more than 13987 patients, provided insight into
                            associations of diabetic nephropathy, diabetic peripheral
                            neuropathy, and diabetic retinopathy with time in range
                            among patients with type 2 diabetes.
                        </p>
                        <p>
                            For the purpose of analysis, Raj et al., performed a
comprehensive literature search of the PubMed, Scopus,
and Web of Science databases on June 5, 2021, for studies
published from 2010 to June 2021. For inclusion, studies
needed to be published in English. Search terms used
in the query included continuous glucose monitor,
continuous glucose monitoring, Dexcom, Freestyle Libre,
Guardian, flash glucose monitoring, time in range, timein-
range, or TIR, diabetes complications, microvascular
complications, retinopathy, neuropathy, nephropathy,
complication, microalbuminuria, or albuminuria, and
type II diabetes or type 2 diabetes. The initial search
identified 110 publications for possible inclusion.

                        </p>
    
                </div>
    
                <div class="col-lg-6 col-sm-12">
                    <p>
                        After exclusion of duplicates and further screening, a
group of 11 articles were identified for inclusion in the
systematic review. These 11 studies included a population
of 13,987 patients, with a median sample size of 466
(range: 105- 5901, IQR: 616). Of the 11 included, 10 were
cross sectional in design and the remaining study was an
interim analysis of an ongoing prospective observational
study. The study population had a mean of 59.3 (SD, 1.3)
years, the mean HbA<sub>1c</sub> at baseline was 8.2% (SD, 0.5%), and
the mean duration of diabetes was 11.3 (SD, 1.0) years.
                    </p>
                    <p>
                        A group of 4 studies examined the association between
time in range and diabetic retinopathy. In these 4
studies, results indicated a 10% increase in time in range
was associated with a reduction in severity of diabetic
retinopathy and increased time spent in target range
was associated with a decrease in the severity of diabetic
retinopathy. Investigators also pointed out time-inrange
was similar to HbA<sub>1c</sub> for predicting diabetic retinopathy in
patients with type 2 diabetes.
                    </p>
                    <p>
                        Similarly, a group of 4 studies examined the association
between time-in-range and diabetic nephropathy.
In these studies, a 10% increase in time-in-range was
associated with a decrease in albuminuria. Additionally, a
single study demonstrated increased time-in-range was
associated with a lower risk of macroalbuminuria and
diabetic kidney disease.
                    </p>
                    <p>
                        A total of 7 studies assessed the relationship between
time-in-range and diabetic neuropathy while 4 studies
examined time-in-range and diabetic painful neuropathy.
                    </p>
                    <p>
                        Analysis of these studies indicated increased time-inrange
was associated with a decrease in the prevalence
and severity of diabetic painful neuropathy and
cardiovascular autonomic neuropathy.
                    </p>
                    <div class="purple-quote primary-bg">
                        <div class="quotes"><img src="./img/quotes.png" alt=""></div>
                        <h3>Conclusion</h3>
                        <p>
                            This study affirms the significant association
between CGM-derived TIR and microvascular
complications of diabetic nephropathy, diabetic
retinopathy, and diabetic painful neuropathy
among patients with type 2 diabetes mellitus
                        </p>
                    </div>
                    
                </div>
            </div>
            
            <div class="article-footer">
                <div class="row">
                    <div class="col-lg-6 col-sm-12">
                        <div class="ref-rating">
                            <p>
                                SD, standard deviation; HbA<sub>1c</sub>
                                , hemoglobin A1c; CGM, continuous glucose
                                monitoring; TIR, time-in-range                            </p>                    
                        </div>
                        <div class="rating">
                            <p>How do you rate this article?</p>
                            <div class="row px-4">
                                <div class="col p-1"><a href="https://dta.eu.qualtrics.com/jfe/form/SV_efWbOu2lUz2aZpQ?CO=EG&Q_Language=EN&Brand=Unbranded&CN=Diabetes_360_eMagazine&Channel=E-NewsLetter&Function=Medical&Franchise=Diabetes_Core&TA=Diabetes&DA=Type_2_Diabetes&R=1" target="_blank"><img src="./img/red-1.png" alt="rate1"></a></div>
                                <div class="col p-1"><a href="https://dta.eu.qualtrics.com/jfe/form/SV_efWbOu2lUz2aZpQ?CO=EG&Q_Language=EN&Brand=Unbranded&CN=Diabetes_360_eMagazine&Channel=E-NewsLetter&Function=Medical&Franchise=Diabetes_Core&TA=Diabetes&DA=Type_2_Diabetes&R=2" target="_blank"><img src="./img/orange-2.png" alt="rate2"></a></div>
                                <div class="col p-1"><a href="https://dta.eu.qualtrics.com/jfe/form/SV_efWbOu2lUz2aZpQ?CO=EG&Q_Language=EN&Brand=Unbranded&CN=Diabetes_360_eMagazine&Channel=E-NewsLetter&Function=Medical&Franchise=Diabetes_Core&TA=Diabetes&DA=Type_2_Diabetes&R=3" target="_blank"><img src="./img/mustard-3.png" alt="rate3"></a></div>
                                <div class="col p-1"><a href="https://dta.eu.qualtrics.com/jfe/form/SV_efWbOu2lUz2aZpQ?CO=EG&Q_Language=EN&Brand=Unbranded&CN=Diabetes_360_eMagazine&Channel=E-NewsLetter&Function=Medical&Franchise=Diabetes_Core&TA=Diabetes&DA=Type_2_Diabetes&R=4" target="_blank"><img src="./img/yellow-4.png" alt="rate4"></a></div>
                                <div class="col p-1"><a href="https://dta.eu.qualtrics.com/jfe/form/SV_efWbOu2lUz2aZpQ?CO=EG&Q_Language=EN&Brand=Unbranded&CN=Diabetes_360_eMagazine&Channel=E-NewsLetter&Function=Medical&Franchise=Diabetes_Core&TA=Diabetes&DA=Type_2_Diabetes&R=5" target="_blank"><img src="./img/green-5.png" alt="rate5"></a></div>
                                <div class="col p-1"><a href="https://dta.eu.qualtrics.com/jfe/form/SV_efWbOu2lUz2aZpQ?CO=EG&Q_Language=EN&Brand=Unbranded&CN=Diabetes_360_eMagazine&Channel=E-NewsLetter&Function=Medical&Franchise=Diabetes_Core&TA=Diabetes&DA=Type_2_Diabetes&R=6" target="_blank"><img src="./img/turquoise-6.png" alt="rate6"></a></div>
                                <div class="col p-1"><a href="https://dta.eu.qualtrics.com/jfe/form/SV_efWbOu2lUz2aZpQ?CO=EG&Q_Language=EN&Brand=Unbranded&CN=Diabetes_360_eMagazine&Channel=E-NewsLetter&Function=Medical&Franchise=Diabetes_Core&TA=Diabetes&DA=Type_2_Diabetes&R=3" target="_blank"><img src="./img/aquamarine-7.png" alt="rate7"></a></div>
                            </div>
                            <div class="rating-bar">
                                <img src="./img/rating-1-5.png" alt="">
                            </div>  
                        </div>
                    </div>
                </div>
            </div>
        </article>
        </div>
        <footer class="footer">
            <div class="pages-header-footer">
                <div class="row">
                    <div class="col-1">
                        <div class="pagination">
                            <p>11</p>
                        </div>
                    </div>
                    <div class="col-8 align-content-center p-0">
                        <div class="dark-line"></div>
                    </div>
                    <div class="col-3 d-flex justify-content-center align-items-center">
                        <div class="header-txt-black header-txt">The 360 e-Magazine</div>
                    </div>
                </div>
            </div>
        
    </footer>

        </div>

    </div>    
    </div>


    <script src="./js/bootstrap.bundle.min.js"></script>
    </body>
</html>